American Journal of Kidney Diseases

Predicting Progression in CKD: Perspectives and Precautions

Published:December 22, 2015DOI:
      Predicting outcomes to guide clinical care, decision making, and resource allocation is a challenging undertaking in chronic kidney disease (CKD). Many prediction models have been developed, but few have been appropriately externally validated and even fewer have been assessed to be usable in the clinical setting. This contributes to the currently infrequent use of existing prediction models. Patients with CKD are a particularly heterogeneous group with significant biological variability, making the development of useful prediction models even more challenging. This article explores the different challenges in the development, validation, and application of prediction models in CKD. We explore the notion that newer biomarkers offer potential for enhancing existing and future prediction models and that modern technology is an opportunity to make prediction models more accessible and less cumbersome to use in clinical practice. Despite the challenges associated with their development and implementation, clinical prediction models have the potential to be a powerful tool for clinicians, researchers, and policy makers alike.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Vickers A.J.
        • Elkin E.B.
        Decision curve analysis: a novel method for evaluating prediction models.
        Med Decis Making. 2006; 26: 565-574
        • Reilly B.M.
        • Evans A.T.
        Translating clinical research into clinical practice: impact of using prediction rules to make decisions.
        Ann Intern Med. 2006; 144: 201-209
        • Collins G.S.
        • Reitsma J.B.
        • Altman D.G.
        • Moons K.G.
        Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement.
        BMJ. 2015; 350: g7594
        • Steyerberg E.W.
        • Vickers A.J.
        • Cook N.R.
        • et al.
        Assessing the performance of prediction models: a framework for traditional and novel measures.
        Epidemiology. 2010; 21: 128-138
        • Hosmer D.W.
        • Hosmer T.
        • Le Cessie S.
        • Lemeshow S.
        A comparison of goodness-of-fit tests for the logistic regression model.
        Stat Med. 1997; 16: 965-980
        • Hilden J.
        • Gerds T.A.
        A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
        Stat Med. 2014; 33: 3405-3414
        • Vickers A.J.
        • Pepe M.
        Does the net reclassification improvement help us evaluate models and markers?.
        Ann Intern Med. 2014; 160: 136-137
        • Vickers A.J.
        • Cronin A.M.
        Everything you always wanted to know about evaluating prediction models (but were too afraid to ask).
        Urology. 2010; 76: 1298-1301
        • Tangri N.
        • Kitsios G.D.
        • Inker L.A.
        • et al.
        Risk prediction models for patients with chronic kidney disease: a systematic review.
        Ann Intern Med. 2013; 158: 596-603
        • Collins G.S.
        • Omar O.
        • Shanyinde M.
        • Yu L.M.
        A systematic review finds prediction models for chronic kidney disease were poorly reported and often developed using inappropriate methods.
        J Clin Epidemiol. 2013; 66: 268-277
        • Rigatto C.
        • Sood M.M.
        • Tangri N.
        Risk prediction in chronic kidney disease: pitfalls and caveats.
        Curr Opin Nephrol Hypertens. 2012; 21: 612-618
        • Echouffo-Tcheugui J.B.
        • Kengne A.P.
        Risk models to predict chronic kidney disease and its progression: a systematic review.
        PLoS Med. 2012; 9: e1001344
        • Bang H.
        • Vupputuri S.
        • Shoham D.A.
        • et al.
        SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease.
        Arch Intern Med. 2007; 167: 374-381
        • Taal M.W.
        Predicting renal risk in the general population: do we have the right formula?.
        Clin J Am Soc Nephrol. 2011; 6: 1523-1525
        • Brenner B.M.
        • Cooper M.E.
        • de Zeeuw D.
        • et al.
        Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
        N Engl J Med. 2001; 345: 861-869
        • Tangri N.
        • Stevens L.A.
        • Griffith J.
        • et al.
        A predictive model for progression of chronic kidney disease to kidney failure.
        JAMA. 2011; 305: 1553-1559
        • Hsu C.Y.
        • Propert K.
        • Xie D.
        • et al.
        Measured GFR does not outperform estimated GFR in predicting CKD-related complications.
        J Am Soc Nephrol. 2011; 22: 1931-1937
        • Weiner D.E.
        • Tighiouart H.
        • Elsayed E.F.
        • et al.
        The Framingham predictive instrument in chronic kidney disease.
        J Am Coll Cardiol. 2007; 50: 217-224
        • Levin A.
        • Warnock D.G.
        • Mehta R.L.
        • et al.
        Improving outcomes from acute kidney injury: report of an initiative.
        Am J Kidney Dis. 2007; 50: 1-4
        • Levey A.S.
        • Coresh J.
        Chronic kidney disease.
        Lancet. 2012; 379: 165-180
        • Go A.S.
        • Chertow G.M.
        • Fan D.
        • McCulloch C.E.
        • Hsu C.Y.
        Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
        N Engl J Med. 2004; 351: 1296-1305
        • Chertow G.M.
        • Soroko S.H.
        • Paganini E.P.
        • et al.
        Mortality after acute renal failure: models for prognostic stratification and risk adjustment.
        Kidney Int. 2006; 70: 1120-1126
        • Chapin E.
        • Zhan M.
        • Hsu V.D.
        • Seliger S.L.
        • Walker L.D.
        • Fink J.C.
        Adverse safety events in chronic kidney disease: the frequency of “multiple hits.”.
        Clin J Am Soc Nephrol. 2010; 5: 95-101
        • Iseki K.
        Gender differences in chronic kidney disease.
        Kidney Int. 2008; 74: 415-417
        • Hemmelgarn B.R.
        • Zhang J.
        • Manns B.J.
        • et al.
        Progression of kidney dysfunction in the community-dwelling elderly.
        Kidney Int. 2006; 69: 2155-2161
        • Parsa A.
        • Kao W.H.
        • Xie D.
        • et al.
        APOL1 risk variants, race, and progression of chronic kidney disease.
        N Engl J Med. 2013; 369: 2183-2196
        • Barbour S.J.
        • Cattran D.C.
        • Kim S.J.
        • et al.
        Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.
        Kidney Int. 2013; 84: 1017-1024
        • Moons K.G.
        • Altman D.G.
        • Vergouwe Y.
        • Royston P.
        Prognosis and prognostic research: application and impact of prognostic models in clinical practice.
        BMJ. 2009; 338: b606
        • Moons K.G.
        • Kengne A.P.
        • Grobbee D.E.
        • et al.
        Risk prediction models: II. External validation, model updating, and impact assessment.
        Heart. 2012; 98: 691-698
        • Peralta C.A.
        • Shlipak M.G.
        • Judd S.
        • et al.
        Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.
        JAMA. 2011; 305: 1545-1552
        • Desai A.S.
        • Toto R.
        • Jarolim P.
        • et al.
        Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
        Am J Kidney Dis. 2011; 58: 717-728
        • Isakova T.
        Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease.
        Curr Opin Nephrol Hypertens. 2012; 21: 334-340
        • Pletcher M.J.
        • Pignone M.
        Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact.
        Circulation. 2011; 123: 1116-1124
        • Feldman H.I.
        • Appel L.J.
        • Chertow G.M.
        • et al.
        The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods.
        J Am Soc Nephrol. 2003; 14: S148-S153
        • Imai E.
        • Matsuo S.
        • Makino H.
        • et al.
        Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
        Hypertens Res. 2008; 31: 1101-1107
        • Gao B.
        • Zhang L.
        • Wang H.
        • Zhao M.
        Chinese cohort study of chronic kidney disease: design and methods.
        Chin Med J (Engl). 2014; 127: 2180-2185
        • Eckardt K.U.
        • Barthlein B.
        • Baid-Agrawal S.
        • et al.
        The German Chronic Kidney Disease (GCKD) study: design and methods.
        Nephrol Dial Transplant. 2012; 27: 1454-1460
        • Levin A.
        • Rigatto C.
        • Brendan B.
        • et al.
        Cohort profile: Canadian study of prediction of death, dialysis and interim cardiovascular events (CanPREDDICT).
        BMC Nephrol. 2013; 14: 121
        • Venuthurupalli S.K.
        • Hoy W.E.
        • Healy H.G.
        • Salisbury A.
        • Fassett R.G.
        • Group C.Q.
        CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.
        Nephrol Dial Transplant. 2012; 27: iii139-iii145
        • Mahmood S.S.
        • Levy D.
        • Vasan R.S.
        • Wang T.J.
        The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.
        Lancet. 2014; 383: 999-1008
        • Lee T.H.
        • Marcantonio E.R.
        • Mangione C.M.
        • et al.
        Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
        Circulation. 1999; 100: 1043-1049
        • Gage B.F.
        • van Walraven C.
        • Pearce L.
        • et al.
        Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.
        Circulation. 2004; 110: 2287-2292
        • Arozullah A.M.
        • Daley J.
        • Henderson W.G.
        • Khuri S.F.
        Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program.
        Ann Surg. 2000; 232: 242-253
        • Mehran R.
        • Aymong E.D.
        • Nikolsky E.
        • et al.
        A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
        J Am Coll Cardiol. 2004; 44: 1393-1399
        • Kanis J.A.
        • Johnell O.
        • Oden A.
        • Johansson H.
        • McCloskey E.
        FRAX and the assessment of fracture probability in men and women from the UK.
        Osteoporos Int. 2008; 19: 385-397
        • Cohen L.M.
        • Ruthazer R.
        • Moss A.H.
        • Germain M.J.
        Predicting six-month mortality for patients who are on maintenance hemodialysis.
        Clin J Am Soc Nephrol. 2010; 5: 72-79
        • Paetzer R.E.
        iChoose Kidney Risk Calculator.
        Emory University School of Medicine, Atlanta, GA2014 (2014 [October 2, 2015]) (Accessed December 21, 2015)
        • Rao P.S.
        • Schaubel D.E.
        • Guidinger M.K.
        • et al.
        A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index.
        Transplantation. 2009; 88: 231-236